发布求助
文献互助 智能选刊 最新文献

Allergo Journal最新文献

筛选
英文 中文
Systemisch getriggerte Kontaktdermatitis durch Scampi Scampi引起的系统性接触性皮炎
IF 1
Allergo Journal Pub Date : 2025-09-15 DOI: 10.1007/s15007-025-6553-9
Saskia Hieber
{"title":"Systemisch getriggerte Kontaktdermatitis durch Scampi","authors":"Saskia Hieber","doi":"10.1007/s15007-025-6553-9","DOIUrl":"10.1007/s15007-025-6553-9","url":null,"abstract":"","PeriodicalId":7418,"journal":{"name":"Allergo Journal","volume":"34 6","pages":"8 - 9"},"PeriodicalIF":1.0,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145057655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CRSwNP: Real-Word-Daten bestätigen Effektivität von Dupilumab CRSwNP：真实世界的数据证实了Dupilumab的有效性。
IF 1
Allergo Journal Pub Date : 2025-09-15 DOI: 10.1007/s15007-025-6547-7
Angelika Bauer-Delto
{"title":"CRSwNP: Real-Word-Daten bestätigen Effektivität von Dupilumab","authors":"Angelika Bauer-Delto","doi":"10.1007/s15007-025-6547-7","DOIUrl":"10.1007/s15007-025-6547-7","url":null,"abstract":"","PeriodicalId":7418,"journal":{"name":"Allergo Journal","volume":"34 6","pages":"115 - 115"},"PeriodicalIF":1.0,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145057658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AeDA-Präsident erhält Auszeichnung der EAACI AeDA主席获得EAACI奖
IF 1
Allergo Journal Pub Date : 2025-09-15 DOI: 10.1007/s15007-025-6555-7
AeDA Geschäftsstelle
{"title":"AeDA-Präsident erhält Auszeichnung der EAACI","authors":"AeDA Geschäftsstelle","doi":"10.1007/s15007-025-6555-7","DOIUrl":"10.1007/s15007-025-6555-7","url":null,"abstract":"","PeriodicalId":7418,"journal":{"name":"Allergo Journal","volume":"34 6","pages":"117 - 117"},"PeriodicalIF":1.0,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145057629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Je mehr Extreme, desto mehr Ekzeme
IF 1
Allergo Journal Pub Date : 2025-09-15 DOI: 10.1007/s15007-025-6562-8
Moritz Borchers
{"title":"Je mehr Extreme, desto mehr Ekzeme","authors":"Moritz Borchers","doi":"10.1007/s15007-025-6562-8","DOIUrl":"10.1007/s15007-025-6562-8","url":null,"abstract":"","PeriodicalId":7418,"journal":{"name":"Allergo Journal","volume":"34 6","pages":"10 - 11"},"PeriodicalIF":1.0,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145057614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Standardtherapie der atopischen Dermatitis - ein Update 特应性皮炎的标准治疗-更新
IF 1
Allergo Journal Pub Date : 2025-09-15 DOI: 10.1007/s15007-025-6543-y
Lisa Anna Perzynski
{"title":"Standardtherapie der atopischen Dermatitis - ein Update","authors":"Lisa Anna Perzynski","doi":"10.1007/s15007-025-6543-y","DOIUrl":"10.1007/s15007-025-6543-y","url":null,"abstract":"<p>Die atopische Dermatitis (AD) ist die häufigste chronisch-entzündliche Hauterkrankung und benötigt eine individualisierte leitlinienbasierte Therapie. Dieser narrative Review gibt ein Update über die Standardtherapie der AD, abhängig vom Schweregrad, orientiert an der Stufentherapie der Leitlinie zur AD (deutsche AWMF-S3-Leitline „Atopische Dermatitis“). Die AD wird in drei Schweregrade eingeteilt: leicht, moderat/mittelschwer und schwer. Bei allen Ausprägungen wird eine konsequente topische Basistherapie und die Meidung von potenziellen Triggerfaktoren empfohlen. Die konsequente Basistherapie/Hautpflege wird auch bei ekzemfreier trockener Haut zur Prävention sowie während eines Schubes angeraten. Ab leichten bis moderaten Ekzemen soll eine zusätzliche antientzündliche Therapie mit topischen Glukokortikoiden und topischen Calcineurin-Inhibitoren zum Einsatz kommen. Bei der mittelschweren bis schweren AD mit unzureichendem Ansprechen auf die vorherigen Maßnahmen ist die Indikation zur Systemtherapie, gegebenenfalls UV-Therapie gegeben. Die Systemtherapien werden in konventionelle und zielgerichtete Systemtherapien (Biologika und Januskinase-Inhibitoren) eingeteilt. Systemische Glukokortikoide sollten nur für maximal drei Wochen als Rescue-Therapie eingesetzt werden. Als steroidsparende langfristige Systemtherapie werden die zielgerichteten Therapien mit höchster Empfehlungsstärke angegeben. Zu den konventionellen steroidsparenden Systemtherapien gehören Ciclosporin A (CiA), Azathioprin (AZT), Methotrexat (MTX) und Mycophenolat-Mofetil (MMF). Hiervon ist nur CiA für die schwere AD ab 16 Jahren zugelassen. MTX sollte, MMF kann - bei Erwachsenen auch AZT - gemäß der S3-Leitlinie der AD im Off-Label-Use erwogen werden.</p><p><b>Zitierweise:</b> Perzynski LA. Update on conventional therapy of atopic dermatitis. Allergo J Int 2025;34:173-9</p><p>https://doi.org/10.1007/s40629-025-00346-8</p>","PeriodicalId":7418,"journal":{"name":"Allergo Journal","volume":"34 6","pages":"38 - 45"},"PeriodicalIF":1.0,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145057631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Schwere Anaphylaxie: besondere Vorsicht bei Kindern mit Nahrungsmittelallergien! 严重过敏：对食物过敏的儿童特别小心！
IF 1
Allergo Journal Pub Date : 2025-09-15 DOI: 10.1007/s15007-025-6558-4
Sabrina Kempe
{"title":"Schwere Anaphylaxie: besondere Vorsicht bei Kindern mit Nahrungsmittelallergien!","authors":"Sabrina Kempe","doi":"10.1007/s15007-025-6558-4","DOIUrl":"10.1007/s15007-025-6558-4","url":null,"abstract":"","PeriodicalId":7418,"journal":{"name":"Allergo Journal","volume":"34 6","pages":"16 - 16"},"PeriodicalIF":1.0,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145057650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
10 Jahre Mepolizumab: Interleukin-5-Inhibition hat sich bewährt Mepolizumab：白细胞介素5抑制10年
IF 1
Allergo Journal Pub Date : 2025-09-15 DOI: 10.1007/s15007-025-6550-z
Redaktion Facharztmagazine
{"title":"10 Jahre Mepolizumab: Interleukin-5-Inhibition hat sich bewährt","authors":"Redaktion Facharztmagazine","doi":"10.1007/s15007-025-6550-z","DOIUrl":"10.1007/s15007-025-6550-z","url":null,"abstract":"","PeriodicalId":7418,"journal":{"name":"Allergo Journal","volume":"34 6","pages":"114 - 114"},"PeriodicalIF":1.0,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145057588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atopische Dermatitis: JAK-Inhibition mit schnellem Wirkeintritt “特应性皮炎：JAK抑制”。
IF 1
Allergo Journal Pub Date : 2025-09-15 DOI: 10.1007/s15007-025-6548-6
Abdol A. Ameri
{"title":"Atopische Dermatitis: JAK-Inhibition mit schnellem Wirkeintritt","authors":"Abdol A. Ameri","doi":"10.1007/s15007-025-6548-6","DOIUrl":"10.1007/s15007-025-6548-6","url":null,"abstract":"","PeriodicalId":7418,"journal":{"name":"Allergo Journal","volume":"34 6","pages":"115 - 115"},"PeriodicalIF":1.0,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145057598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Step by Step: Online-Archiv, ePaper und CME-Fortbildung 一步一步：在线档案，纸质文件和cme - forbildung
IF 1
Allergo Journal Pub Date : 2025-09-15 DOI: 10.1007/s15007-025-6554-8
{"title":"Step by Step: Online-Archiv, ePaper und CME-Fortbildung","authors":"","doi":"10.1007/s15007-025-6554-8","DOIUrl":"10.1007/s15007-025-6554-8","url":null,"abstract":"","PeriodicalId":7418,"journal":{"name":"Allergo Journal","volume":"34 6","pages":"118 - 118"},"PeriodicalIF":1.0,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145057653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Welche Arzneimittel lösen am häufigsten eine Anaphylaxie aus? 哪些药物最容易引起过敏反应？
IF 1
Allergo Journal Pub Date : 2025-09-15 DOI: 10.1007/s15007-025-6556-6
Kathrin von Kieseritzky
{"title":"Welche Arzneimittel lösen am häufigsten eine Anaphylaxie aus?","authors":"Kathrin von Kieseritzky","doi":"10.1007/s15007-025-6556-6","DOIUrl":"10.1007/s15007-025-6556-6","url":null,"abstract":"","PeriodicalId":7418,"journal":{"name":"Allergo Journal","volume":"34 6","pages":"17 - 17"},"PeriodicalIF":1.0,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145057586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信